Comparing clinical outcomes in upper versus lower lobe endobronchial valve treatment in severe emphysema

Respiration

Volumn 90, Issue 4, 2015, Pages 314-320

  Eberhardt, Ralf ^a,b   Herth, Felix J F ^a,b   Radhakrishnan, Sri ^c   Gompelmann, Daniela ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b German Center for Lung Research   (Germany)

^c Clinical Research Dept   (United States)

Author keywords

Heterogeneity; Lung emphysema; Outcome; Valve treatment

Indexed keywords

6 MIN WALK TEST; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSESSMENT OF HUMANS; COHORT ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EMPHYSEMA; LUNG LOBE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; EMPHYSEMA; LUNG SURGERY; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

AGED; EMPHYSEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84946493573     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000437358     Document Type: Article

References (31)

1. Vestbo J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365
2. ODonnell, Denis E. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 180-184
3. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010; 35: 676-680
4. Gelb A, Zamel N, McKenna R, Brenner M. Mechanism of short-term improvement in lung function after emphysema resection. Am J Respir Crit Care Med 1996; 154: 945-951
5. Gelb AF, McKenna RJ Jr, Brenner M, Fischel R, Baydur A, Zamel N. Contribution of lung and chest wall mechanics following emphysema resection. Chest 1996; 110: 11-17
6. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ Jr, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc 2008; 5: 416-420
7. Naunheim KS, Wood DE, Krasna MJ, De-Camp MM Jr, Ginsburg ME, McKenna RJ Jr, Criner GJ, Hoffman EA, Sternberg AL, Deschamps C. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006; 131: 43-53
8. Sciurba F, Ernst A, Herth F, Strange C, Criner G, Marquette C, Kovitz K, Chiacchierini R, Goldin J, McLennan G. A randomized study of endobronchical valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244
9. Herth FJ, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39: 1334-1342
10. Strange C, Herth FJ, Kovitz KL, McLennan G, Ernst A, Goldin J, Noppen M, Criner GJ, Sciurba FC; for the VENT Study Group: Design of the endobronchial valve for emphysema palliation trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med 2007; 7: 10
11. Abtin F, Goldin J, Strange C, et al. The influence of fissural anatomy on the treatment outcome of patients with emphysema (poster No. 4036). Poster presentation at the American Thoracic Society, Toronto, May 2008
12. Abtin F, Goldin J, Brown M, et al. Variation in fissure anatomy in emphysema patients treated with endobronchial valve (poster No. 4125). Poster presentation at American Thoracic Society, Toronto, May 2008
13. Cazzola M, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-468
14. Puhan MA, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790
15. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404
16. Hartman JE, et al. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J 2012; 40: 1137-1141
17. Valipour A, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J 2014; 43: 387-396
18. Coxson H, Nasute Fauerbach PV, Storness-Bliss C, Muller NL, Cogswell S, Dillard DH, Finger CL, Springmeyer SC. Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J 2008; 32: 1443-1450
19. Eberhardt R, et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142: 900-908
20. Wood DE, et al. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol 2014; 12: 288-297
21. Ninane V, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39: 1319-1325
22. Arschang V, Kramer MR, Stanzel F, Kempa A, Asadi S, Fruchter O, Eberhardt R, Herth FJ, Ingenito EP. Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema. Front Physiol 2012; 3: 387
23. Weder W, Tutic M, Lardinois D, Jungraithmayr W, Hillinger S, Russi EW, Bloch KE. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Ann Thorac Surg 2009; 87: 229-237
24. Tutic M, Bloch KE, Lardinois D, Brack T, Russi EW, Weder W. Long-term results after lung volume reduction surgery in patients with 1-antitrypsin deficiency. J Thorac Cardiovasc Surg 2004; 128: 408-413
25. Weder W, Thurnheer R, Stammberger U, Burge M, Russi EW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 1997; 64: 313-320
26. Gelb AF, McKenna RJ, Brenner M, Fischel R, Zamel N. Lung function after bilateral lower lobe lung volume reduction surgery for alpha1-antitrypsin emphysema. Eur Respir J 1999; 14: 928-933
27. DeCamp MM, McKenna RJ, Deschamps CC, Krasna MJ. Lung volume reduction surgery: technique, operative mortality, and morbidity. Proc Am Thorac Soc 2008; 5: 442-446
28. Tuohy MM, Remund KF, Hilfiker R, Murphy DT, Murray JG, Egan JJ. Endobronchial valve deployment in severe α-1 antitrypsin deficiency emphysema: a case series. Clin Respir J 2013; 7: 45-52
29. Hillerdal G, Mindus S. One-to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series. Respiration 2014; 88: 320-328
30. Sterman DH, Mehta AC, Wood DE, et al. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration 2010; 79: 222-233
31. Gompelmann D, Herth FJ, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87: 485-491